Table 2.
Malignant | 46 (71%) |
Adenocarcinoma | 23 (35%) |
Squamous cell carcinoma | 18 (28%) |
Large cell neuroendocrine carcinoma | 3 (4%) |
Squamous cell (95%) and neuroendocrine carcinoma | 1 (2%) |
Small cell carcinoma | 1 (2%) |
Benign | 19 (29%) |
Inflammatory infiltrations | 9 (14%) |
Sarcoidosis | 5 (8%) |
Fibroma | 2 (4%) |
Hamartoma | 1 (1%) |
Hematoma | 1 (1%) |
Tuberculoma | 1 (1%) |